Physician profile
Mary Storts
NPI 1952958472
$3,201.05
in general payments reported to CMS, 2019-2025
23 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $535 · 2022: $396 · 2023: $858 · 2024: $385 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,269.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $594.79 | 2023-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $366.60 | 2022-2025 | |
| Shockwave Medical, INC | $315.98 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $306.80 | 2021-2025 | Lifevest |
| Amgen INC. | $215.59 | 2021-2025 | Repatha, Repatha |
| Organogenesis INC. | $186.60 | 2021-2023 | Puraply |
| Merck Sharp & Dohme LLC | $164.38 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $154.28 | 2022-2025 | Farxiga, Andexxa |
| Impulse Dynamics (USA) INC. | $154.23 | 2022-2024 | Optimizer, Optimizer |
| Terumo Medical Corporation | $146.77 | 2021-2023 | Glidewire |
| Janssen Pharmaceuticals, INC | $124.90 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $90.15 | 2021-2025 | General - Vascular Intervention |
| Novo Nordisk INC | $59.35 | 2021-2025 | Wegovy |
| Cardiovascular Systems INC. | $54.13 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $51.57 | 2022-2023 | Assure Wcd |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $47.65 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kiniksa Pharmaceuticals International, Plc | $37.59 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.04 | 2021 | |
| Sanofi-Aventis U.S. LLC | $27.67 | 2023 | |
| Medtronic, INC. | $20.95 | 2025 | Turbohawk |
| Inspire Medical Systems, INC. | $18.45 | 2024 | Inspire |
| Pfizer INC. | $15.26 | 2025 | |
| Advanced Oxygen Therapy INC. | $11.32 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Storts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.